Stephen Eisennagel

653 total citations · 1 hit paper
12 papers, 480 citations indexed

About

Stephen Eisennagel is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Stephen Eisennagel has authored 12 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Hematology. Recurrent topics in Stephen Eisennagel's work include Chemical Synthesis and Analysis (3 papers), Click Chemistry and Applications (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). Stephen Eisennagel is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Click Chemistry and Applications (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). Stephen Eisennagel collaborates with scholars based in United States, Australia and Israel. Stephen Eisennagel's co-authors include Bruce E. Tomczuk, Megha Basavappa, Christoph A. Thaiss, Sasikanth Manne, Walter K. Mowel, Jorge Henao‐Mejia, Sam J. McCright, Anthony Virtue, Sean P. Spencer and Leonel Joannas and has published in prestigious journals such as Journal of Medicinal Chemistry, Science Translational Medicine and Urology.

In The Last Decade

Stephen Eisennagel

12 papers receiving 467 citations

Hit Papers

The gut microbiota regulates white adipose tissue inflamm... 2019 2026 2021 2023 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs
    2019 243 citations Anthony Virtue, Sam J. McCright et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Eisennagel United States 8 266 126 97 50 48 12 480
E. Cama United States 9 206 0.8× 95 0.8× 74 0.8× 130 2.6× 39 0.8× 9 575
Rudy N. Van Coster Belgium 13 434 1.6× 109 0.9× 98 1.0× 52 1.0× 62 1.3× 18 723
Silvia Funghini Italy 17 231 0.9× 66 0.5× 41 0.4× 38 0.8× 37 0.8× 36 567
YOSHIO YOSHIOKA Japan 10 194 0.7× 80 0.6× 115 1.2× 35 0.7× 34 0.7× 15 466
Fredrik Tholander Sweden 12 290 1.1× 101 0.8× 48 0.5× 46 0.9× 33 0.7× 20 550
Robert Mintzer United States 10 567 2.1× 77 0.6× 115 1.2× 10 0.2× 24 0.5× 10 709
Roger P. Dickinson United Kingdom 15 215 0.8× 46 0.4× 266 2.7× 45 0.9× 18 0.4× 26 636
Nahed K. Ahmed United States 13 272 1.0× 56 0.4× 29 0.3× 14 0.3× 65 1.4× 30 533
Yoshikazu Sukenaga Japan 12 225 0.8× 34 0.3× 47 0.5× 21 0.4× 32 0.7× 22 435
Bradley T. Keller United States 16 212 0.8× 30 0.2× 82 0.8× 17 0.3× 193 4.0× 21 764

Countries citing papers authored by Stephen Eisennagel

Since Specialization
Citations

This map shows the geographic impact of Stephen Eisennagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Eisennagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Eisennagel more than expected).

Fields of papers citing papers by Stephen Eisennagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Eisennagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Eisennagel. The network helps show where Stephen Eisennagel may publish in the future.

Co-authorship network of co-authors of Stephen Eisennagel

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Eisennagel. A scholar is included among the top collaborators of Stephen Eisennagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Eisennagel. Stephen Eisennagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Virtue, Anthony, Sam J. McCright, Jasmine M. Wright, et al.. (2019). The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Science Translational Medicine. 11(496). 243 indexed citations breakdown →
2.
Morgan, Lisa, Alan R. Olzinski, John J. Upson, et al.. (2012). Soluble Epoxide Hydrolase Inhibition Does Not Prevent Cardiac Remodeling and Dysfunction After Aortic Constriction in Rats and Mice. Journal of Cardiovascular Pharmacology. 61(4). 291–301. 22 indexed citations
3.
Kompa, Andrew R., Bing H. Wang, Guoying Xu, et al.. (2012). Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction. International Journal of Cardiology. 167(1). 210–219. 40 indexed citations
4.
Jugus, M, et al.. (2012). Voltage-gated Na+ Channel Blockers Reduce Functional Bladder Capacity in the Conscious Spontaneously Hypertensive Rat. Urology. 79(6). 1410.e1–1410.e6. 5 indexed citations
5.
Subasinghe, Nalin L., Ehab M. Khalil, Jeremy Travins, et al.. (2012). Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s. Bioorganic & Medicinal Chemistry Letters. 22(16). 5303–5307. 7 indexed citations
6.
Kreutter, K. D., Tianbao Lu, Lily Lee, et al.. (2008). Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif. Bioorganic & Medicinal Chemistry Letters. 18(9). 2865–2870. 24 indexed citations
7.
Chen, Yanmin, Stephen Eisennagel, Malini Dasgupta, et al.. (2008). Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog andin vitrodrug metabolism. Biopharmaceutics & Drug Disposition. 29(3). 127–138. 1 indexed citations
8.
Chaikin, Margery A., Juan Marugán, Gerald W. De Vries, et al.. (2005). A functional radioreceptor assay of alpha-V-beta-3 (αvβ3) inhibitors in plasma: Application as an ex vivo pharmacodynamic model. Journal of Biochemical and Biophysical Methods. 65(2-3). 107–120. 1 indexed citations
9.
Marugán, Juan, Carl L. Manthey, Tianbao Lu, et al.. (2005). Design, Synthesis, and Biological Evaluation of Novel Potent and Selective αvβ3/αvβ5 Integrin Dual Inhibitors with Improved Bioavailability. Selection of the Molecular Core. Journal of Medicinal Chemistry. 48(4). 926–934. 61 indexed citations
10.
Lu, Tianbao, Frank T. Coppo, Bruce E. Tomczuk, et al.. (2004). Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis. Bioorganic & Medicinal Chemistry Letters. 14(14). 3727–3731. 19 indexed citations
11.
Tomczuk, Bruce E., Tianbao Lu, Richard Söll, et al.. (2003). Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1495–1498. 24 indexed citations
12.
Söll, Richard, Bruce E. Tomczuk, Carl R. Illig, et al.. (2000). Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(1). 1–4. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Cama Breakdown of academic impact, for papers by Rudy N. Van Coster Breakdown of academic impact, for papers by Silvia Funghini Breakdown of academic impact, for papers by YOSHIO YOSHIOKA Breakdown of academic impact, for papers by Fredrik Tholander Breakdown of academic impact, for papers by Robert Mintzer Breakdown of academic impact, for papers by Roger P. Dickinson Breakdown of academic impact, for papers by Nahed K. Ahmed Breakdown of academic impact, for papers by Yoshikazu Sukenaga Breakdown of academic impact, for papers by Bradley T. Keller
Rankless by CCL
2026